Results 71 to 80 of about 3,194,118 (301)

A year in review – evaluating the launch of IJTLD OPEN

IJTLD Open
One year on from the launch of our new open access (OA) journal, IJTLD OPEN, we review its impact. Similar to our flagship journal, the IJTLD, articles published in IJTLD OPEN span a range of topics related to lung health and the majority focus on TB in ...
H.D. Blackbourn, G.B. Migliori
doaj   +1 more source

Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Keratin 19 (KRT19) is overexpressed in high‐grade serous ovarian cancer with high levels of Kallikrein‐related peptidases (KLK) 4–7 and is associated with poor survival. In vivo analyses demonstrate that elevated KRT19 increases peritoneal tumour burden.
Sophia Bielesch, Isabel Vogel, Sina Nokodian, Johanna Moeller, Antonia Blechschmidt, Vicky Hecht, Vanessa Kuentzel, Katharina Thiedig, Melissa Schwab, Oliver Schilling, Holger Bronger, Marion Kiechle, Viktor Magdolen, Tobias Dreyer   +13 more
wiley   +1 more source

The Year in 2012

, 2013
10.25818/jans-nb8f1-29IPS Year in Review (Institute of Policy ...
Valerie Koh, Debbie Soon
core   +1 more source

Establishment of a humanized patient‐derived xenograft mouse model of high‐grade serous ovarian cancer for preclinical evaluation of combination immunotherapy

Molecular Oncology, EarlyView.
We have established a humanized orthotopic patient‐derived xenograft (Hu‐oPDX) mouse model of high‐grade serous ovarian cancer (HGSOC) that recapitulates human tumor–immune interactions. Using combined anti‐PD‐L1/anti‐CD73 immunotherapy, we demonstrate the model's improved biological relevance and enhanced translational value for preclinical ...
Luka Tandaric, Line Bjørge, Martine Rott Lode, Cecilie Fredvik Torkildsen, Pia Aehnlich, Rammah Elnour, Daniela Elena Costea, Lars Andreas Akslen, Liv Cecilie Vestrheim Thomsen, Emmet McCormack, Katrin Kleinmanns   +10 more
wiley   +1 more source

From the Editors: Making Intangible Capital a better review in its third year

Intangible Capital, 2007
With this issue, Intangible Capital reaches its third year. It is a good moment to reflect on how can we make this review better one along this year, and to asses if we have achieved the second year’s goal.
Pep Simo
doaj   +1 more source

The Year in 2011

, 2012
10.25818/5ym1-dhbc1-18IPS Year in Review (Institute of Policy ...
Debbie Soon
core   +1 more source

CD47 promotes mitogen‐activated protein kinase and epithelial‐to‐mesenchymal transition molecular programs to drive prometastatic phenotypes in non‐small cell lung cancer

Molecular Oncology, EarlyView.
Beyond its role in immune evasion, this study identified that CD47 drives tumor‐intrinsic signaling in non‐small cell lung cancer (NSCLC). Transcriptomic profiling and functional studies revealed that CD47 regulates cell adhesion, migration, and metastasis through an ERK–EMT signaling axis.
Asa P.Y. Lau, Lilian G. Zhai, Ryunosuke Hoshi, Zackary Rousseau, Abraam Zakhary, Yin Fang Wu, Rola M. Saleeb, Heyu Ni, Kelsie L. Thu   +8 more
wiley   +1 more source

One Year Retrospective Review of Forensic Reports Reported in the Emergency Department

Namık Kemal Tıp Dergisi
Aim: It was aimed to investigate the characteristics of forensic cases admitted to the emergency department of Tekirdağ Namık Kemal University Hospital (TNKUH), the qualities of forensic reports and the prognosis of the cases. Materials and Methods: All
Sercan BIÇAKÇI, Nurcan BIÇAKÇI, Hüseyin ŞAHİN, Naile Esra SAKA, Elif ÇAMCI   +4 more
doaj   +1 more source

Year in Review 2018 by the Brazilian Gastrointestinal Tumors Group - GTG: Gastrointestinal Tumors

Brazilian Journal of Oncology, 2019
In 2018, there were some important trials presented over multiple international meetings. The objective of this article is to summarize the most important and practice changing studies in gastrointestinal oncology this year.
Anelisa K. Coutinho, Gabriel Prolla, Gustavo dos Santos Fernandes, Heber Salvador, Renata D'Alpino Peixoto, Rui F. Weschenfelder   +5 more
doaj   +1 more source

Cell‐cycle‐specific lesion evolution rather than inhibition of double‐strand‐break repair underpins cisplatin radiosensitization

Molecular Oncology, EarlyView.
We analyze cisplatin–DNA adducts (CDAs) and double‐strand breaks (DSBs) in a cell‐cycle‐dependent manner. We find that CDAs form similarly across all cell cycle phases. DSBs arise only in S‐phase. CDAs might not directly impair DSB repair, but S‐phase DSB lesions evolve in the presence of CDAs and disrupt repair in G2, also causing radiosensitization ...
Ye Qiu, Xixi Lin, Emil Mladenov, Veronika Mladenova, Jürgen Thomale, Ali Sak, Yao Wang, Yunxuan Deng, Eleni Gkika, Martin Stuschke, George Iliakis   +10 more
wiley   +1 more source